Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Growth Factors for Subacromial Impingement
NCT04330027Unknown
- Sponsor
- Alexandria University
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Other Cell Types
- Countries
- 1
01
Overview
Randomised, double-blind trial of allogenic lyophilized growth factors in shoulder impingement syndrome (SIS) (2 arms), sponsored by Alexandria University. Primary endpoints: Visual Analogue Scale at 8 weeks and Shoulder Pain and Disability Index at 8 weeks. Status: unknown.
02
Drugs
allogenic lyophilized growth factors
03
Conditions
shoulder impingement syndrome (SIS)
Beyond the preview
Go deeper on NCT04330027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330027.